Aprea Therapeutics financial statements

Name: Quantus Signal — KR/US technical signal dataset
License: https://www.quantus.kr/signal/terms

아프레아 테라퓨틱스NASDAQ:APRE · Nasdaq · Healthcare

$0.6756-2.79%

2026-10-05 close · prelim

Aprea Therapeutics's published financial data is dated 2026-10-04. 2024 revenue was $2M. 2024 operating profit was −$14M.

Reported results

Quantus Signal · live data · not investment advice · Privacy Policy